THE 5-HYDROXYTRYPTAMINE CONTENT OF THE PLACENTA AND FOETUS DURING PREGNANCY IN MICE.
5-Hydroxytryptamine (5HT) levels were measured in blood and tissues from pregnant mice. Blood levels remained constant during pregnancy and were the same as those in nonpregnant female mice. Placental levels of 5HT increased throughout pregnancy as did the foetal levels. The maternal blood volume of the placenta also increased with advancing gestation. 5HT levels were measured after treatment of the mother with 5HT, and the critical placental level of 5HT observed at about the time of death of the foetus was determined. The levels of 5HT in the placenta and foetus after treatment of the mother with several monoamine oxidase inhibitors were measured, and found to show no significant increase above the normal levels in these tissues. Treatment with cyproheptadine, a 5HT antagonist, did not delay parturition.
D000818:Animals; D001774:Blood Chemical Analysis; D001811:Blood Volume Determination; D003533:Cyproheptadine; D005260:Female; D005333:Fetus; D006801:Humans; D007490:Iproniazid; D051379:Mice; D008996:Monoamine Oxidase Inhibitors; D036801:Parturition; D010600:Pharmacology; D010920:Placenta; D011247:Pregnancy; D011270:Pregnancy, Animal; D012106:Research; D012701:Serotonin; D014191:Tranylcypromine
D008996:Monoamine Oxidase Inhibitors; D003533:Cyproheptadine; D012701:Serotonin; D014191:Tranylcypromine; D007490:Iproniazid
BLOOD CHEMICAL ANALYSIS; BLOOD VOLUME DETERMINATION; CYPROHEPTADINE; EXPERIMENTAL LAB STUDY; FETUS; IPRONIAZID; MICE; MONOAMINE OXIDASE INHIBITORS; PHARMACOLOGY; PLACENTA; PREGNANCY; PREGNANCY, ANIMAL; SEROTONIN; TRANYLCYPROMINE